Glucose in Dialysis Water in Diabetics With Chronic Renal Failure

Regional Hospital Holstebro18 enrolled

Overview

The purposes are 1. to measure the effect of dialysis with glucose in dialysis water on blood pressure, pulse rate, plasma concentration of glucose, plasma concentrations og insulin, glucagon, growth hormone, renin, angiotensin II, endothelin and body temperature, and 2. to analyse the relationship between the changes in blood pressure and changes in vasoactive hormones

The relationship between blood pressure during dialysis treatment and vasoactive hormones are studied. This includes measurements of plasma concentration of glucose, plasma concentrations og insulin, glucagon, growth hormone, renin, angiotensin II, endothelin

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Renal Failure, Chronic Diabetic Nephropathies

Interventions

ProcedurePROCEDURE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age \> 18 years, 2. Both men and women, 3. Dialysis treatment for at least three month due to diabetic nephropathy Exclusion Criteria: 1. Heart failure, 2. Lung insufficiency, 3. Chronic liver disease, 4. Malignant disease, 5. Nephrotic syndrome, 6. Lack of compliance, 7. Unwillingness to participate

Locations (1)

Holstebro Hospital

Holstebro, Denmark

Outcomes

Primary Outcomes

Effect og glucose in dialysis water on blood pressure, plasma glucose and hormones in plasma

Secondary Outcomes

Relationship between changes in blood pressure and and changes in hormones

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.